ISRG - NASDAQ

Intuitive Surgical, Inc.

ISRG·NASDAQ

$407.29

+1.2%

HealthcareMedical - Devices

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$144.25B

EPS8.0000

P/E Ratio50.91

Earnings Date07/28/2026

20.63B

Assets

10%

3Y+59.0%

5Y+85.0%

10Y+218.0%

2.69B

Total Liabilities

16%

3Y+44.0%

5Y+91.0%

10Y+279.0%

17.94B

Total Equity

3Y+61.0%

5Y+83.0%

10Y+211.0%

Intuitive Surgical, Inc. Funding & Solvency Profile

ISRG · NASDAQ

Current Assets

Cash & Cash Equivalents3.37B

Net Receivables1.63B

Inventory1.84B

Other Current Assets376.40M

Total Current Assets10 B

Non-Current Assets

Property, Plant & Equipment5.34B

Goodwill & Intangible Assets381.40M

Long-Term Investments3.30B

Other Non-Current Assets810.80M

Total Non-Current Assets9 B

Total Assets

20.63B

Financial Health Analysis

Current Ratio

4.87x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.15x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

8 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

47% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Intuitive Surgical, Inc. Balance Sheet

ISRG • NASDAQ

Intuitive Surgical, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	3.4B	2B	2.8B	1.6B	1.3B	1.6B	1.2B	857.9M	3.8B	4.8B	3.3B	2.5B	782.1M	553.7M	2.2B	1.6B	1.2B	194.6M	122.8M	34.4M
Short-Term Investments	2.6B	2B	2.5B	2.5B	2.9B	3.5B	2.1B	2.2B	0.0	0.0	0.0	0.0	621.4M	770.7M	0.0	0.0	0.0	256.7M	304.6M	205.4M
Cash & Short-Term Investments	5.9B	4B	5.2B	4.1B	4.2B	5.2B	3.2B	3.1B	3.8B	4.8B	3.3B	2.5B	1.4B	1.3B	2.2B	1.6B	1.2B	451.4M	427.5M	239.7M
Net Receivables	1.6B	1.4B	1.3B	1.1B	893M	726.6M	708.3M	682.3M	507.9M	430.2M	394.3M	315.1M	301.4M	370.3M	297.9M	246.8M	205.4M	170.1M	130.4M	94.7M
Accounts Receivables	1.5B	1.2B	1.1B	942.1M	782.7M	645.5M	645.2M	682.3M	507.9M	430.2M	394.3M	315.1M	301.4M	370.3M	297.9M	246.8M	205.4M	170.1M	130.4M	94.7M
Other Receivables	100.9M	131.4M	137.3M	131.2M	110.3M	81.1M	63.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	1.8B	1.5B	1.2B	893.2M	587.1M	601.5M	595.5M	409M	241.2M	182.3M	167.9M	181.7M	179.6M	121.5M	112.1M	86.8M	57.6M	63.5M	32.4M	24.3M
Prepaids	0.0	0.0	0.0	162.5M	4.3M	126.3M	137.1M	41.4M	55.2M	41.7M	73.5M	82.6M	38.3M	67.3M	20.9M	23.3M	21.4M	9.5M	13.5M	6.3M
Other Current Assets	376.4M	253.7M	176.7M	6.1M	129.6M	0.0	0.0	137.4M	2.1M	41.6M	0.0	35.1M	9.6M	76.6M	27.1M	31.8M	28.2M	19M	19.3M	15.7M
Total Current Assets	9.8B	7.1B	7.9B	6.3B	5.8B	6.6B	4.7B	4.3B	4.7B	5.5B	3.9B	3B	1.9B	1.9B	2.6B	2B	1.4B	703.9M	609.6M	374.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	5.3B	4.8B	3.5B	2.4B	1.9B	1.6B	1.3B	812M	613.1M	458.4M	432.1M	387.4M	309.9M	241.8M	197.2M	159.8M	125.7M	117M	68.1M	59.9M
Goodwill	370.3M	347.5M	348.7M	348.5M	343.6M	336.7M	307.2M	240.6M	201.1M	201.1M	201.1M	198M	137.4M	138.1M	116.9M	116.9M	110.7M	110.7M	110.7M	118.2M
Intangible Assets	11.1M	23M	39.1M	49.8M	70.5M	77.4M	112.1M	66.7M	26M	31.5M	49.7M	74.1M	94.1M	83.6M	71M	66.1M	56.2M	56.2M	23.5M	5.8M
Goodwill & Intangible Assets	381.4M	370.5M	387.8M	398.3M	414.1M	414.1M	419.3M	307.3M	227.1M	232.6M	250.8M	272.1M	231.5M	221.7M	187.9M	183M	166.9M	167M	134.2M	124.1M
Long-Term Investments	3.3B	5.1B	2.1B	2.6B	4.4B	1.8B	2.6B	1.8B	1.9B	2.3B	1.8B	1.3B	1.4B	1.6B	1.1B	698.5M	616.5M	451M	208M	91M
Tax Assets	1B	1.1B	910.5M	664.6M	441.4M	367.7M	425.6M	428.6M	87.3M	150.9M	167.8M	171.3M	126.1M	0.0	75.3M	73.3M	60.7M	35.9M	18.7M	22.3M
Other Non-Current Assets	810.8M	369M	597.6M	660.3M	562.7M	426.2M	329.3M	194.3M	-1.7B	-2.1B	-1.6B	-1.1B	0.0	-2.1B	-1.1B	-682.4M	-539M	-150K	1.4M	74K
Total Non-Current Assets	10.9B	11.7B	7.6B	6.7B	7.7B	4.5B	5.1B	3.5B	1.1B	1B	997.3M	965.6M	2B	2.1B	481.3M	366.1M	374.8M	770.7M	430.4M	297.3M
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	20.6B	18.8B	15.4B	13B	13.6B	11.2B	9.7B	7.8B	5.8B	6.5B	4.9B	4B	4B	4.1B	3.1B	2.4B	1.8B	1.5B	1B	671.8M
LIABILITIES
CURRENT LIABILITIES
Total Payables	380.5M	347.8M	300.1M	243.1M	175.3M	128.8M	161.4M	139.8M	82.5M	108.9M	64M	69M	51.3M	63.4M	54.3M	55.3M	27.6M	20.5M	29.8M	11.1M
Accounts Payable	255.1M	193.4M	188.7M	147M	121.2M	81.6M	123.5M	100.7M	82.5M	68.5M	52.6M	61.6M	46.2M	57.6M	45.8M	35.6M	27.6M	20.5M	29.8M	11.1M
Other Payables	125.4M	154.4M	111.4M	96.1M	54.1M	47.2M	37.9M	39.1M	0.0	40.4M	11.4M	7.4M	5.1M	5.8M	8.5M	19.7M	12K	0.0	0.0	0.0
Accrued Expenses	470.6M	535.6M	476.1M	380.1M	235.2M	240.7M	243.7M	188.1M	105.8M	136.4M	117.3M	96.2M	70.7M	104M	83.1M	63.4M	49.8M	36.9M	30.1M	21.1M
Short Term Debt	39M	33.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	125.4M	0.0	111.4M	96.1M	54.1M	47.2M	37.9M	39.1M	63.1M	40.4M	11.4M	7.4M	5.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	506.7M	468.8M	446.1M	397.3M	377.2M	350.3M	337.8M	294.3M	302.8M	249.9M	230.1M	221.9M	200.1M	0.0	155.2M	126.9M	100.5M	78M	53.8M	36.6M
Other Current Liabilities	609.4M	359.6M	436.4M	401.6M	362.1M	245.4M	287.3M	198.4M	230.7M	110.6M	85M	119.4M	58.8M	344M	29M	29M	95.7M	29.1M	18.1M	11.9M
Total Current Liabilities	2B	1.7B	1.7B	1.4B	1.1B	965.2M	1B	820.6M	1B	709.1M	587.8M	580M	380.9M	401.6M	417.5M	353M	272.4M	164.5M	131.8M	80.7M
NON-CURRENT LIABILITIES
Long Term Debt	131.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue (Non-Current)	91.4M	54.1M	45.6M	41M	36.8M	32.1M	27.4M	33M	24.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1M	1.3M	875K	0.0
Deferred Tax Liabilities (Non-Current)	172.5M	95.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.2M	126.1M	0.0	69.1M	73.3M	53.3M	35.9M	18.7M	22.3M
Other Non-Current Liabilities	155.6M	301.7M	339.9M	398.3M	329.9M	412.5M	390.9M	305.6M	308.8M	112.6M	95.9M	78.8M	68M	0.0	27.8M	79.2M	15.3M	42.1M	18.7M	1.4M
Total Non-Current Liabilities	683.3M	563.7M	385.5M	439.3M	453.7M	444.6M	418.3M	338.6M	327.1M	112.6M	95.9M	78.8M	68M	0.0	96.9M	79.2M	69.7M	43.3M	19.6M	1.4M
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-327.1M	-112.6M	-95.9M	-78.8M	0.0	0.0	-96.9M	-79.2M	-69.7M	0.0	0.0	0.0
Capital Lease Obligations	131.9M	112.5M	0.0	0.0	87M	0.0	68.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	2.7B	2.3B	2B	1.9B	1.6B	1.4B	1.4B	1.2B	1B	709.1M	587.8M	580M	448.9M	479.1M	417.5M	353M	272.4M	207.9M	151.3M	82.1M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	50.4M	27.6M	20.9M	0.0	1.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	400K	400K	400K	400K	400K	100K	100K	100K	100K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38K	39K	38K	37K
Additional Paid-In Capital	10.8B	9.7B	8.6B	7.7B	7.2B	6.4B	5.8B	5.2B	4.7B	4.2B	3.4B	2.9B	2.5B	2.2B	1.7B	1.3B	1B	871.8M	694.6M	537.9M
Retained Earnings	7B	6.8B	4.7B	3.5B	4.8B	3.3B	2.5B	1.5B	61.4M	1.6B	899.2M	487.7M	979.4M	1.3B	901.9M	718.9M	511.7M	397.8M	193.5M	51M
Accumulated Other Comprehensive Income/Loss	43.3M	-51.3M	-12.2M	-162.5M	-24.2M	24.9M	12.4M	-13.3M	-15.5M	-8.9M	-9.5M	-5.1M	2.1M	0.0	900K	1.6M	1.3M	-2.9M	530K	705K
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2B	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	17.8B	16.4B	13.3B	11B	12B	9.8B	8.3B	6.7B	4.7B	5.8B	4.3B	3.4B	3.5B	3.6B	2.6B	2B	1.5B	1.3B	888.7M	589.7M
Total Equity	17.9B	16.5B	13.4B	11.1B	12B	9.8B	8.3B	6.7B	4.7B	5.8B	4.3B	3.4B	3.5B	3.6B	2.6B	2B	1.5B	1.3B	888.7M	589.7M
Minority Interest	117.7M	95.9M	89.7M	70.7M	50.4M	27.6M	20.9M	8.7M	1.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	20.6B	18.8B	15.4B	13B	13.6B	11.2B	9.7B	7.8B	5.8B	6.5B	4.9B	4B	4B	0.0	3.1B	2.4B	1.8B	1.5B	1B	671.8M
Total Investments	5.9B	7.1B	4.6B	5.2B	7.4B	5.3B	4.7B	4B	1.9B	2.3B	1.8B	1.3B	2B	2.4B	1.1B	698.5M	616.5M	707.7M	512.6M	296.4M
Total Debt	302.8M	146M	0.0	0.0	87M	0.0	76.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Debt	-3.1B	-1.9B	-2.8B	-1.6B	-1.2B	-1.6B	-1.1B	-857.9M	-3.8B	-4.8B	-3.3B	-2.5B	-782.1M	0.0	-2.2B	-1.6B	-1.2B	-194.6M	-122.8M	-34.4M
Shares Outstanding	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469	357,230,469

SEC Filings

ISRG - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 28, 2026	May 28, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	April 30, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 22, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 21, 2026	April 21, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	March 13, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 02, 2026	March 01, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 03, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 22, 2026	January 22, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 14, 2026	January 14, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 18, 2025	December 16, 2025	2025	View Filing

Showing 1 to 10 of 358 filings

Related Guides

Blog Categories

Continue your ISRG research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.